Global Health Limited — PPTs, 04-02-2026: Investor Presentation

Medanta (Global Health) showed a solid Q3 FY26.

**Business Performance:** Total Income jumped 19.1% YoY to INR 1,142.8 Cr. Core hospital profitability (EBITDA ex-Noida) grew 10.9% YoY to INR 281.4 Cr (25.4% margin). However, reported profit after tax (PAT) dipped to INR 95 Cr (-33.5% YoY) due to initial setup costs/depreciation at the new Noida hospital and a one-time charge for new Labour Codes. Patient numbers surged, with in-patients up 14.3% and out-patients up 19.5%. Average revenue per occupied bed (ARPOB) rose 9.9% to INR 67,361.

**Growth Drivers/Strategy:** The company is in expansion mode, adding 144 beds in Q3 FY26 (537 beds in 9M FY26) and attracting 110 new doctors. Key strategies include deploying cutting-edge medical tech and boosting 'continuity of care' with more collection centers and pharmacies.

**Recent Developments:** Medanta Noida is now fully operational with 328 beds. Big expansion plans are in motion for Delhi (Pitampura & South Delhi), Mumbai, and Guwahati, promising thousands of new beds.

**Management Commentary / Outlook:** Management aims for sustained growth by expanding bed capacity, investing in talent and technology, and broadening clinical services. They project a significant capex of over INR 3,901.3 Cr in the next 5 years for these growth initiatives.